Login to Your Account

Other News To Note

Monday, November 7, 2011

• MiRagen Therapeutics Inc., of Boulder, Colo., published preclinical data showing microRNA-15 is upregulated in response to ischemic damage and contributes to cardiovascular disease. The research confirms that targeting microRNA-15 can spare cardiomyocytes from death during a heart attack. The data were published in Circulation Research.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription